S1 Biopharma, Inc.
PrivateLast Round
IPO
Jun 25, 2015
Est. Valuation
$106M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
S1 Biopharma, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. It was founded in 2008.
S1 Biopharma, Inc. is a biopharmaceutical company that develops non-hormonal drug therapies for the treatment of sexual dysfunction in women and men.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
S1 Biopharma, Inc. Comparables
Compare S1 Biopharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sprout Pharmaceuticals, Inc. | 84% | |
| JASTLabs Corp | 77% | |
| Arletta Pharma Solutions | 77% |
For institutional investors. Book with your work email.
S1 Biopharma, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
S1 Biopharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northland Securities, Inc. | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 97% MoM, reaching 1.7K.
- Jun 22, 2026
Monthly visitors grew 1323% MoM, from 61 to 868.
For institutional investors. Book with your work email.
S1 Biopharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about S1 Biopharma, Inc.'s valuation, stock price, and market status.
Is S1 Biopharma, Inc. a public or private company?
S1 Biopharma, Inc. is a private company.
What is the current stock price of S1 Biopharma, Inc.?
S1 Biopharma, Inc. is a private company, so its shares have no public market price. Caplight tracks S1 Biopharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is S1 Biopharma, Inc. worth (valuation)?
S1 Biopharma, Inc.'s valuation is estimated at $106.0M based on funding round data.
Can I buy S1 Biopharma, Inc. stock?
S1 Biopharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was S1 Biopharma, Inc.'s last funding round?
S1 Biopharma, Inc.'s most recent funding round was IPO on June 25, 2015.
Who are the main investors in S1 Biopharma, Inc.?
Key investors in S1 Biopharma, Inc. include Northland Securities, Inc..
Will S1 Biopharma, Inc. IPO soon?
No public IPO plans have been announced for S1 Biopharma, Inc..
How can I track S1 Biopharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in S1 Biopharma, Inc.'s shares on secondary markets.